The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Modelling finds PrEP has the potential to avert between 3 and 8% of HIV infections in 13 African and Caribbean countries by 2030 if three key populations can access it
Despite the country’s successful treatment programme, modelling suggests the rate of new infections is likely to rise – unless prevention is strengthened and groups such as migrants included.
South African trial finds 90% of people receiving rapid viral load testing were virally suppressed and in care after 12 months, compared to 76% who waited for tests.
Malawi trial finds half of those offered the opportunity to self-test for HIV during an outpatient visit accepted it, compared to less than 15% of those offered provider-initiated testing.
Evidence review finds approximately half of hospital patients with cryptococcal, tuberculosis or pneumococcal meningitis died within two weeks or during hospitalisation.
Study among transgender women and men who have sex with men finds those who opt for online supervised HIV-self testing are more likely to test positive but less likely to seek treatment than those testing offline.
Viral load testing trial finds 49% are virally unsuppressed while one in five are failing their treatment with suspected drug resistance.
Research on PrEP safety for pregnant women and their babies finds no adverse effects – but knowledge gaps remain.
Mobile testing and door-to-door approaches result in a 25% increase in status awareness, with particularly significant gains in diagnosing HIV-positive young people and men.
Study with transgender women suggests taking on-demand PrEP with hormone therapy may result in drug levels too low for HIV prevention.